Cost and antibiotic utilization of pneumonia patients in intensive care unit

Ramya Kateel, Prabha Adhikari, Sheetal Rajm

Research output: Contribution to journalArticle

Abstract

Objective of this study is to evaluate the cost and antibiotic utilization of pneumonia patients admitted in intensive care unit. It was a retrospective study. Details required for antibiotic utilization and cost analysis were acquired from hospital files. Out of 320 cases evaluated 110 cases were of pneumonia.28.2% of people had pneumonia as their primary diagnosis and 71.8% had hospital acquired/aspiration pneumonia. The mean length of ICU stay was 3.30± 1.91 days. 21.8% patients were put on ventilator. The mortality rate was 34.5%. Betalactum along with betalactamase inhibitor antibiotics were prescribed for 91% patients, Carbapenams for 20%, anti-staphylococcal antibiotic for 51% of patients and macrolides and miscellaneous antibiotics were prescribed in 25.5% and 36.4% patients respectively. Betalactum antibiotic along with betalactamase inhibitor and clindamycin combination was most commonly prescribed antibiotic. Average cost per patient who was not put on ventilator was Rs 27,123 where as ventilated patient per cost was Rs44, 812. This study showed that one third of ICU admissions was due to pneumonia. Highest numbers of pneumonia were hospital acquired/aspiration pneumonia. Cost of ventilator supported pneumonia was two times more than non-ventilated pneumonia. Ventilator support was the most expensive intervention adding to the cost of care followed by cost of antibiotics and investigations.

Original languageEnglish
Pages (from-to)87-90
Number of pages4
JournalJournal of Applied Pharmaceutical Science
Volume6
Issue number2
DOIs
Publication statusPublished - 01-01-2016
Externally publishedYes

Fingerprint

Intensive Care Units
Pneumonia
Anti-Bacterial Agents
Costs and Cost Analysis
Mechanical Ventilators
Aspiration Pneumonia
Clindamycin
Macrolides
Length of Stay
Retrospective Studies
Mortality

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)

Cite this

Kateel, Ramya ; Adhikari, Prabha ; Rajm, Sheetal. / Cost and antibiotic utilization of pneumonia patients in intensive care unit. In: Journal of Applied Pharmaceutical Science. 2016 ; Vol. 6, No. 2. pp. 87-90.
@article{d5d8099fd7494d78bb26cfd1e4c526dd,
title = "Cost and antibiotic utilization of pneumonia patients in intensive care unit",
abstract = "Objective of this study is to evaluate the cost and antibiotic utilization of pneumonia patients admitted in intensive care unit. It was a retrospective study. Details required for antibiotic utilization and cost analysis were acquired from hospital files. Out of 320 cases evaluated 110 cases were of pneumonia.28.2{\%} of people had pneumonia as their primary diagnosis and 71.8{\%} had hospital acquired/aspiration pneumonia. The mean length of ICU stay was 3.30± 1.91 days. 21.8{\%} patients were put on ventilator. The mortality rate was 34.5{\%}. Betalactum along with betalactamase inhibitor antibiotics were prescribed for 91{\%} patients, Carbapenams for 20{\%}, anti-staphylococcal antibiotic for 51{\%} of patients and macrolides and miscellaneous antibiotics were prescribed in 25.5{\%} and 36.4{\%} patients respectively. Betalactum antibiotic along with betalactamase inhibitor and clindamycin combination was most commonly prescribed antibiotic. Average cost per patient who was not put on ventilator was Rs 27,123 where as ventilated patient per cost was Rs44, 812. This study showed that one third of ICU admissions was due to pneumonia. Highest numbers of pneumonia were hospital acquired/aspiration pneumonia. Cost of ventilator supported pneumonia was two times more than non-ventilated pneumonia. Ventilator support was the most expensive intervention adding to the cost of care followed by cost of antibiotics and investigations.",
author = "Ramya Kateel and Prabha Adhikari and Sheetal Rajm",
year = "2016",
month = "1",
day = "1",
doi = "10.7324/JAPS.2016.60212",
language = "English",
volume = "6",
pages = "87--90",
journal = "Journal of Applied Pharmaceutical Science",
issn = "2231-3354",
publisher = "MediPoeia",
number = "2",

}

Cost and antibiotic utilization of pneumonia patients in intensive care unit. / Kateel, Ramya; Adhikari, Prabha; Rajm, Sheetal.

In: Journal of Applied Pharmaceutical Science, Vol. 6, No. 2, 01.01.2016, p. 87-90.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cost and antibiotic utilization of pneumonia patients in intensive care unit

AU - Kateel, Ramya

AU - Adhikari, Prabha

AU - Rajm, Sheetal

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Objective of this study is to evaluate the cost and antibiotic utilization of pneumonia patients admitted in intensive care unit. It was a retrospective study. Details required for antibiotic utilization and cost analysis were acquired from hospital files. Out of 320 cases evaluated 110 cases were of pneumonia.28.2% of people had pneumonia as their primary diagnosis and 71.8% had hospital acquired/aspiration pneumonia. The mean length of ICU stay was 3.30± 1.91 days. 21.8% patients were put on ventilator. The mortality rate was 34.5%. Betalactum along with betalactamase inhibitor antibiotics were prescribed for 91% patients, Carbapenams for 20%, anti-staphylococcal antibiotic for 51% of patients and macrolides and miscellaneous antibiotics were prescribed in 25.5% and 36.4% patients respectively. Betalactum antibiotic along with betalactamase inhibitor and clindamycin combination was most commonly prescribed antibiotic. Average cost per patient who was not put on ventilator was Rs 27,123 where as ventilated patient per cost was Rs44, 812. This study showed that one third of ICU admissions was due to pneumonia. Highest numbers of pneumonia were hospital acquired/aspiration pneumonia. Cost of ventilator supported pneumonia was two times more than non-ventilated pneumonia. Ventilator support was the most expensive intervention adding to the cost of care followed by cost of antibiotics and investigations.

AB - Objective of this study is to evaluate the cost and antibiotic utilization of pneumonia patients admitted in intensive care unit. It was a retrospective study. Details required for antibiotic utilization and cost analysis were acquired from hospital files. Out of 320 cases evaluated 110 cases were of pneumonia.28.2% of people had pneumonia as their primary diagnosis and 71.8% had hospital acquired/aspiration pneumonia. The mean length of ICU stay was 3.30± 1.91 days. 21.8% patients were put on ventilator. The mortality rate was 34.5%. Betalactum along with betalactamase inhibitor antibiotics were prescribed for 91% patients, Carbapenams for 20%, anti-staphylococcal antibiotic for 51% of patients and macrolides and miscellaneous antibiotics were prescribed in 25.5% and 36.4% patients respectively. Betalactum antibiotic along with betalactamase inhibitor and clindamycin combination was most commonly prescribed antibiotic. Average cost per patient who was not put on ventilator was Rs 27,123 where as ventilated patient per cost was Rs44, 812. This study showed that one third of ICU admissions was due to pneumonia. Highest numbers of pneumonia were hospital acquired/aspiration pneumonia. Cost of ventilator supported pneumonia was two times more than non-ventilated pneumonia. Ventilator support was the most expensive intervention adding to the cost of care followed by cost of antibiotics and investigations.

UR - http://www.scopus.com/inward/record.url?scp=84960422485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960422485&partnerID=8YFLogxK

U2 - 10.7324/JAPS.2016.60212

DO - 10.7324/JAPS.2016.60212

M3 - Article

VL - 6

SP - 87

EP - 90

JO - Journal of Applied Pharmaceutical Science

JF - Journal of Applied Pharmaceutical Science

SN - 2231-3354

IS - 2

ER -